UBS Group AG - CYTEK BIOSCIENCES INC ownership

CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 86 filers reported holding CYTEK BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CYTEK BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$3,406
-99.8%
617
-99.7%
0.00%
-100.0%
Q2 2023$1,986,481
+179.6%
232,609
+200.9%
0.00%
Q1 2023$710,515
+54.2%
77,314
+71.4%
0.00%
Q4 2022$460,635
+680.7%
45,116
+1024.2%
0.00%
Q3 2022$59,000
+5800.0%
4,013
+6269.8%
0.00%
Q2 2022$1,000
-94.4%
63
-92.4%
0.00%
Q3 2021$18,0008310.00%
Other shareholders
CYTEK BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Brown Capital Management 13,560,480$74,853,8501.15%
HHLR ADVISORS, LTD. 6,657,030$36,746,8060.82%
RA Capital Management 6,809,404$37,587,9100.74%
Versor Investments LP 33,900$187,1280.04%
SHERBROOKE PARK ADVISERS LLC 15,656$86,4210.03%
NEW YORK STATE COMMON RETIREMENT FUND 2,348,015$12,9610.02%
Quantbot Technologies LP 46,452$256,4150.02%
Grandeur Peak Global Advisors, LLC 33,131$182,8830.01%
SG Americas Securities, LLC 188,813$1,0420.01%
NorthCrest Asset Manangement, LLC 52,050$287,3160.01%
View complete list of CYTEK BIOSCIENCES INC shareholders